Laurus Labs has invested Rs 83.30 crore and acquired 83,300,000 equity shares of KRKA Pharma (KRKA) (a joint venture of the Company) a at face value of Rs 10 each by way of rights issue.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1658.30 |
| Dr. Reddys Lab | 1218.90 |
| Cipla | 1230.95 |
| Zydus Lifesciences | 931.80 |
| Lupin | 2313.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: